Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of the 2nd of December, we are planning to work on 15 projects, including:

Reimbursement

1. Working on reimbursement and procedure volume analysis project for multiple technologies in obstetrics and gynecology in France, Germany, Italy, and Spain
2. Working on policy analysis project, including qualitative interviews, in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 
3. Working on the educational materials on the reimbursement system in the Netherlands
4. Working on the reimbursement analysis for therapeutic drug monitoring in England and France
5. Working on the reimbursement analysis for parenteral drug delivery systems in outpatient specialist and home-based care in Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Spain, Sweden
6. Working on high-level overview of market access pathways for ostomy products in France and Germany 
7. Initiating work on reimbursement analysis for embolization procedures in different indications in England, France, Germany, Italy and Spain
8. Working on an overview of payment mechanisms for hospital procedures and devices in Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Greece, Hungary, the Netherlands, Norway, Romania, Slovakia, Sweden, Switzerland, Turkey 

HEOR

1. Working on the development of an HTA national submission dossier in Sweden
2. Working on the development of a health economic model for neurovascular technology in Belgium, England, France, Germany, Italy, and Spain
3. Working on the development of a health economic model for neuromonitoring technology in England
4. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain
5. Working on the Evidence Gap Analysis for two technologies in the nephrology field
6. Working on the development of the reimbursement application for technology in the neurovascular field in Ireland 
7. Working on the development of the reimbursement application for technology in the neurovascular field in Ireland and Hungary

Let us know if you need any market access or HEOR support for your medical technology in Europe.